Biogen Inc.
BIIB
$139.31
$0.190.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.36% | 1.59% | -1.62% | -3.86% | -3.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.36% | 1.59% | -1.62% | -3.86% | -3.00% |
| Cost of Revenue | 3.28% | -2.82% | -12.28% | -9.21% | -0.78% |
| Gross Profit | 3.39% | 3.02% | 2.07% | -2.09% | -3.67% |
| SG&A Expenses | -3.13% | -3.84% | -4.72% | -8.64% | 6.25% |
| Depreciation & Amortization | 52.13% | 56.31% | 60.64% | 69.60% | 40.79% |
| Other Operating Expenses | 11.47% | 8.62% | 16.27% | 25.99% | 19.69% |
| Total Operating Expenses | -1.84% | -4.96% | -9.54% | -9.26% | 2.01% |
| Operating Income | 21.32% | 26.71% | 31.82% | 16.85% | -17.05% |
| Income Before Tax | 36.82% | 32.43% | 46.98% | 18.46% | -57.91% |
| Income Tax Expenses | 70.95% | 75.06% | 102.37% | 98.57% | -65.72% |
| Earnings from Continuing Operations | 32.21% | 26.73% | 40.53% | 10.42% | -56.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 366.67% | 242.86% |
| Net Income | 32.10% | 26.80% | 40.57% | 10.49% | -56.52% |
| EBIT | 21.32% | 26.71% | 31.82% | 16.85% | -17.05% |
| EBITDA | 23.17% | 28.18% | 32.71% | 19.80% | -11.18% |
| EPS Basic | 31.43% | 26.09% | 39.70% | 9.71% | -56.80% |
| Normalized Basic EPS | 24.40% | 25.91% | 24.57% | 2.00% | -23.52% |
| EPS Diluted | 31.58% | 26.31% | 40.06% | 9.99% | -56.78% |
| Normalized Diluted EPS | 24.50% | 26.13% | 24.77% | 2.19% | -23.37% |
| Average Basic Shares Outstanding | 0.60% | 0.60% | 0.59% | 0.59% | 0.50% |
| Average Diluted Shares Outstanding | 0.55% | 0.48% | 0.48% | 0.50% | 0.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |